Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures

Full text
Author(s):
Hernandez-Gonzalez, Jorge E. [1, 2] ; Salas-Sarduy, Emir [3] ; Hernandez Ramirez, Luisa F. [4] ; Pascual, Maria J. [3] ; Alvarez, Diego E. [3] ; Pabon, Adriana [4] ; Leite, Vitor B. P. [1] ; Pascutti, Pedro G. [5] ; Valiente, Pedro A. [2]
Total Authors: 9
Affiliation:
[1] Univ Estadual Paulista, Dept Fis, UNESP, BR-15054000 Sao Paulo - Brazil
[2] Univ Havana, Fac Biol, Ctr Prot Studies, Computat Biol & Biomol Dynam Lab, Havana - Cuba
[3] Univ Nacl San Martin UNSAM, IIB INTECH, Inst Invest Biotecnol, Inst Tecnol Chascomus, CONICET, Buenos Aires, DF - Argentina
[4] Univ Antioquia, Fac Med, Grp Malaria, Medellin - Colombia
[5] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Dinam & Modelagem Mol, Ave Carlos Chagas Filho, 373 CCS Bloco D Sala 30, BR-21941902 Rio De Janeiro - Brazil
Total Affiliations: 5
Document type: Journal article
Source: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS; v. 1862, n. 12, p. 2911-2923, DEC 2018.
Web of Science Citations: 1
Abstract

Background: Falcipain 2 (FP-2) is the hemoglobin-degrading cysteine protease of Plasmodium falciparum most extensively targeted to develop novel antimalarials. However, no commercial antimalarial drugs based on FP-2 inhibition are available yet due to the low selectivity of most FP-2 inhibitors against the human cysteine pro teases. Methods: A structure-based virtual screening (SVBS) using Maybridge HitFinderr (TM) compound database was conducted to identify potential FP-2 inhibitors. In vitro enzymatic and cell-growth inhibition assays were performed for the top-scoring compounds. Docking, molecular dynamics (MD) simulations and free energy calculations were employed to study the interaction of the best hits with FP-2 and other related enzymes. Results and conclusions: Two hits based on 4-(9H-fluoren-9-yl) piperazin-1-yl) methanone scaffold, HTS07940 and HTS08262, were identified as inhibitors of FP-2 (half-maximal inhibitory concentration (IC50) = 64 mu M and 14.7 mu M, respectively) without a detectable inhibition against the human off-target cathepsin K (hCatK). HTS07940 and HTS08262 inhibited the growth of the multidrug-resistant P. falciparum strain FCR3 in culture (half-maximal inhibitory concentrations (IC50) = 2.91 mu M and 34 mu M, respectively) and exhibited only moderate cytotoxicity against HeLa cells (Half-maximal cytotoxic concentration (CC50) = 133 M mu and 350 mu M, respectively). Free energy calculations reproduced the experimental affinities of the hits for FP-2 and explained the selectivity with respect to hCatK. General significance: To the best of our knowledge, HTS07940 stands among the most selective FP-2 inhibitors identified by SBVS reported so far, displaying moderate antiplasmodial activity and low cytotoxicity against human cells. Hence, this compound constitutes a promising lead for the design of more potent and selective FP-2 inhibitors. (AU)

FAPESP's process: 16/24587-9 - In silico identification of novel competitive and alosteric inhibitors of falcipains 2 and 3
Grantee:Jorge Enrique Hernández González
Support type: Scholarships in Brazil - Doctorate